Indeed, EGFR overexpression has been reported in cancers originating from bladder, brain, breast, cervical, uterine, colon, esophageal, glioma, lung, ovarian, pancreatic, and renal cell3–7, and this dysregulation is often associated with a more aggressive phenotype and accordingly worse survival of the cancer patients8. This evidence concerns the gene EGFR and cancer.